Betahistine Hydrochloride Tablets IP 8mg
Betahistine is indicated for the treatment of vertigo, tinnitus, hearing loss and nausea associated with M©n's syndrome. Initial oral treatment is 8 mg to 16 mg three times daily, taken with food. Maintenance doses are generally in the range 24 “ 48 mg daily. Dosage can be adjusted to suit individual patient needs.